VYNE Therapeutics Inc. (VYNE)
1.77
0.05 (2.91%)
At close: Mar 24, 2025, 3:59 PM
1.75
-1.13%
After-hours: Mar 24, 2025, 04:05 PM EDT
VYNE Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Revenue | 501K | 424K | 477K | 14.76M | 20.99M | 443K | 10.64M | 4.58M | 674K | n/a |
| Cost of Revenue | n/a | n/a | n/a | 3.35M | 1.39M | 350K | n/a | n/a | n/a | n/a |
| Gross Profit | 501K | 424K | 477K | 11.41M | 19.6M | 93K | 10.64M | 4.58M | 674K | n/a |
| Operating Income | -43.64M | -29.26M | -34.3M | -68.03M | -113.47M | -76.24M | -54.53M | -29.59M | -14.33M | -4.61M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 3.09M | 517K | 264K | n/a |
| Pretax Income | -39.8M | -27.87M | -33.93M | -73.78M | -255.83M | -73.7M | -51.45M | -29.08M | -14.07M | -4.61M |
| Net Income | -39.83M | -28.45M | -33.95M | -73.33M | -255.57M | -70.46M | -51.45M | -29.08M | -14.07M | -4.61M |
| Selling & General & Admin | 13.19M | 13.38M | 16.39M | 54.48M | 89.54M | 22.48M | 12.19M | 5.17M | 3.75M | 1.69M |
| Research & Development | 30.95M | 16.31M | 18.39M | 24.96M | 43.53M | 53.76M | 52.99M | 29.01M | 11.26M | 2.92M |
| Other Expenses | n/a | n/a | 363K | -135K | 1.11M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 44.14M | 29.68M | 34.77M | 79.44M | 133.08M | 76.24M | 65.17M | 34.17M | 15.01M | 4.61M |
| Interest Expense | n/a | n/a | n/a | 5.61M | 4.39M | 2.54M | 3.09M | 517K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 44.14M | 29.68M | 34.77M | 82.79M | 134.47M | 76.24M | 65.17M | 34.17M | 15.01M | 4.61M |
| Income Tax | 4K | n/a | 13K | -448K | -258K | -3.24M | 3.09M | -8K | n/a | n/a |
| Shares Outstanding (Basic) | 42.59M | 10.27M | 3.19M | 2.86M | 1.8M | 471.39K | 300.95K | 286.04K | 160.27K | 160.27K |
| Shares Outstanding (Diluted) | 42.59M | 10.27M | 3.19M | 2.86M | 1.8M | 471.39K | 300.95K | 286.04K | 160.27K | 160.27K |
| EPS (Basic) | -0.94 | -2.77 | -10.65 | -25.65 | -141.9 | -149.48 | -170.94 | -101.65 | -87.78 | -28.75 |
| EPS (Diluted) | -0.94 | -2.77 | -10.65 | -25.65 | -141.9 | -149.48 | -170.94 | -101.65 | -87.78 | -28.75 |
| EBITDA | -43.63M | -29.26M | -34.22M | -38.94M | -251.09M | -94.08M | -54.53M | -29.59M | -14.33M | -4.61M |
| Depreciation & Amortization | 4K | n/a | 72K | 109K | 341K | 350K | 22K | 8K | 4K | n/a |